Defender Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Hold
1,100
0.09% 34
2026
Q1
$269K Sell
1,100
-166
-13% -$38.7K 0.1% 31
2025
Q4
$262K Buy
+1,266
New +$250K 0.08% 33
2024
Q4
Sell
-1,266
Closed -$205K 42
2024
Q3
$205K Buy
+1,266
New +$202K 0.07% 33
2024
Q2
Sell
-1,271
Closed -$201K 39
2024
Q1
$201K Buy
+1,271
New +$202K 0.07% 34
2023
Q4
Sell
-1,369
Closed -$213K 40
2023
Q3
$213K Hold
1,369
0.08% 37
2023
Q2
$227K Buy
1,369
+3
+0.2% +$484 0.08% 35
2023
Q1
$212K Hold
1,366
0.07% 34
2022
Q4
$241K Hold
1,366
0.1% 28
2022
Q3
$223K Hold
1,366
0.09% 28
2022
Q2
$242K Hold
1,366
0.09% 30
2022
Q1
$242K Hold
1,366
0.08% 34
2021
Q4
$234K Buy
+1,366
New +$224K 0.08% 40

Other funds holding JNJ

Defender Capital's JNJ Position: Q2 2026 in Review

Defender Capital held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,100 shares worth $279K. The position accounts for 0.09% of the portfolio, ranked #34.

Defender Capital first reported a position in JNJ in Q4 2021 and has held it in 13 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Defender Capital held 1,100 shares of Johnson & Johnson worth $279K as of Q2 2026.
  • Defender Capital left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.09% of Defender Capital's portfolio in Q2 2026, its #34 holding.
  • Defender Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 13 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Defender Capital's 13F filing for Q2 2026, filed 9 Jul 2026.